• You are here: Home > eXpert Advice > Health Notes
Also indexed as: d4T, Stauvudine, Zerit

Stavudine is used to treat human immunodeficiency virus (HIV) infections. It is in a class of drugs known as antivirals.
Summary of
Interactions with Vitamins, Herbs, and Foods
In some cases, a herb or supplement may appear in more than one category, which may seem
contradictory. For clarification, read the full article for details about the summarized
interactions.
|
Acetyl-L-carnitine |
|
|
Acetyl-L-carnitine Vitamin B1* |
|
| Supportive interaction |
None known |
| Reduced drug absorption/bioavailability |
None known |
| Adverse interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Vitamin B1
(thiamine)
A 30-year-old woman who was taking stavudine developed a rare side effect called lactic
acidosis, which was successfully treated with intravenous thiamine.1 Controlled
studies are needed to determine whether lactic acidosis might be prevented if people taking
stavudine supplement with vitamin B1. Until more information is available, some health
practitioners may recommend supplemental vitamin B1 to individuals taking stavudine.
Acetyl-L-carnitine
Severe peripheral neuropathy (painful sensations due to nerve damage in the hands and feet)
often develops in people taking stavudine or other drugs in its class. People with peripheral
neuropathy who were taking one of these drugs were found to be deficient in
acetyl-L-carnitine.2 In a preliminary trial, supplementing with 1,500 mg of
acetyl-L-carnitine twice a day resulted in improvement in the neuropathy after six months in
people taking stavudine or related drugs.3 Similar benefits were seen in another
study that used the same amount of acetyl-L-carnitine.4
1. Schramm C, Wanitschke R, Galle PR. Thiamin for the treatment of nucleoside analogue-induced severe lactic acidosis. Eur J Anaesthesiol 1999;16:733–5.
2. Famularo G, Moretti S, Marcellini S, et al. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 1997;11:185–90.
3. Hart AM, Wilson ADH, Montovani C, et al. Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 2004;18:1549–60.
4. Herzmann C, Johnson MA, Youle M. Long-term effect of acetyl-L-carnitine for antiretroviral toxic neuropathy. HIV Clin Trials 2005;6:344–50.
Copyright © 2006 Healthnotes, Inc. All rights reserved. www.healthnotes.com
Please read the disclaimer about the limitations of the information provided here. Do NOT rely solely on the information in this article.
Learn more about Healthnotes, the company.
Learn more about the authors of Using Medicines with Vitamins and Herbs
The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or chemist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires August 2007.